389 related articles for article (PubMed ID: 21968544)
1. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
[TBL] [Abstract][Full Text] [Related]
2. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
5. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
[TBL] [Abstract][Full Text] [Related]
6. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of response of rheumatoid synovium cell subsets to interleukin-18 in relation to differential interleukin-18 receptor expression.
Kawashima M; Miossec P
Arthritis Rheum; 2003 Mar; 48(3):631-7. PubMed ID: 12632414
[TBL] [Abstract][Full Text] [Related]
8. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
[TBL] [Abstract][Full Text] [Related]
10. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Harada S; Yamamura M; Okamoto H; Morita Y; Kawashima M; Aita T; Makino H
Arthritis Rheum; 1999 Jul; 42(7):1508-16. PubMed ID: 10403280
[TBL] [Abstract][Full Text] [Related]
11. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
[TBL] [Abstract][Full Text] [Related]
12. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
13. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion.
Lubberts E; Joosten LA; Chabaud M; van Den Bersselaar L; Oppers B; Coenen-De Roo CJ; Richards CD; Miossec P; van Den Berg WB
J Clin Invest; 2000 Jun; 105(12):1697-710. PubMed ID: 10862785
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast-like cells in murine collagen induced arthritis.
Suzuki Y; Nishikaku F; Nakatuka M; Koga Y
J Rheumatol; 1998 Jun; 25(6):1154-60. PubMed ID: 9632079
[TBL] [Abstract][Full Text] [Related]
15. An herbal formula inhibits STAT3 signaling and attenuates bone erosion in collagen-induced arthritis rats.
Chen YJ; Wu JY; Leung WC; Liu YX; Fu XQ; Zhu JQ; Wu Y; Chou JY; Yin CL; Wang YP; Wang XQ; Bai JX; Wu ZZ; Yu ZL
Phytomedicine; 2020 May; 76():153254. PubMed ID: 32531698
[TBL] [Abstract][Full Text] [Related]
16. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
[TBL] [Abstract][Full Text] [Related]
17. Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis.
Samarpita S; Rasool M
Cytokine; 2021 Jun; 142():155502. PubMed ID: 33810944
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.
Udagawa N; Kotake S; Kamatani N; Takahashi N; Suda T
Arthritis Res; 2002; 4(5):281-9. PubMed ID: 12223101
[TBL] [Abstract][Full Text] [Related]
19. Bone destruction in arthritis.
Gravallese EM
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines.
Toyosaki-Maeda T; Takano H; Tomita T; Tsuruta Y; Maeda-Tanimura M; Shimaoka Y; Takahashi T; Itoh T; Suzuki R; Ochi T
Arthritis Res; 2001; 3(5):306-10. PubMed ID: 11549372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
